Irx Therapeutics, Inc.
Records under this name other than patents Irx Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Irx Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,993,660 | Method of Increasing Immunological Effect now held by Brooklyn Immunotherapeutics LLC In force · High confidence | In force | High confidence | |
| US 9,333,238 | Method of Immunotherapy for Treament of Human Papillomavirus Infection now held by Brooklyn Immunotherapeutics LLC In force · High confidence | In force | High confidence | |
| US 9,931,378 | Method of Immunotherapy for Treatment of Human Papillomavirus Infection now held by Brooklyn Immunotherapeutics LLC Lapsed on the fee record Ended Apr 3, 2026 · Medium confidence | Lapsed on the fee record | Ended Apr 3, 2026 | Medium confidence |
| US 8,591,956 | Method of Increasing Immunological Effect now held by Brooklyn Immunotherapeutics LLC Lapsed on the fee record Ended Nov 26, 2025 · High confidence | Lapsed on the fee record | Ended Nov 26, 2025 | High confidence |
| US 8,470,562 | IRX-2 Modified Manufacturing Process now held by Brooklyn Immunotherapeutics LLC Lapsed on the fee record Ended Jun 25, 2025 · High confidence | Lapsed on the fee record | Ended Jun 25, 2025 | High confidence |
| US 9,566,331 | Vaccine Immunotherapy now held by Brooklyn Immunotherapeutics LLC Lapsed on the fee record Ended Feb 14, 2025 · High confidence | Lapsed on the fee record | Ended Feb 14, 2025 | High confidence |
| US 7,731,945 | Immunotherapy for Reversing Immune Suppression now held by Brooklyn Immunotherapeutics LLC Term ended Ended no later than Feb 6, 2025 · Medium confidence | Term ended | Ended no later than Feb 6, 2025 | Medium confidence |
| US 9,539,320 | Vaccine Immunotherapy now held by Brooklyn Immunotherapeutics LLC Lapsed on the fee record Ended Jan 10, 2025 · High confidence | Lapsed on the fee record | Ended Jan 10, 2025 | High confidence |
| US 9,492,517 | Vaccine Immunotherapy now held by Brooklyn Immunotherapeutics LLC Term ended Term ended Feb 25, 2024 · High confidence | Term ended | Term ended Feb 25, 2024 | High confidence |
| US 9,789,172 | Vaccine Immunotherapy for Treating Lymphoma in Immune Suppressed Patients now held by Brooklyn Immunotherapeutics LLC Term ended Term ended Aug 17, 2023 · High confidence | Term ended | Term ended Aug 17, 2023 | High confidence |